FDA reviewing Humira, Remicade and Enbrel for cancer risk
According to a notice published today on the Food and Drug Administration website, FDA is investigating the possible association between the use of tumor necrosis factor (TNF) inhibitors and the development of lymphoma and other cancers in children and young adults. These individuals were treated with TNF blockers for Juvenile Idiopathic... Read more

















